Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Aplagon is developing novel treatments for thromboinflammatory diseases. Its lead candidate, APAC, is a first-in-class therapeutic designed to act locally at sites of vascular injury by combining ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Find out the best way to find the right CDMO for your biotech. Experts shared some advice to help companies through the ...